Amivantamab (Anti-HGFR / c-Met)
Amivantamab (Anti-HGFR / c-Met) (A2601-GRP)
Products
Description
Amivantamab (Anti-HGFR/c-Met) is an antibody targeting hepatocyte growth factor receptor (HGFR, also known as c-Met) with immunohistochemical activity against non-small cell lung cancer (NSCLC). MW: 145.88KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2601 |
| Target | EGFR |